French Innovative Leukemia Organization

French Innovative Leukemia Organization - FILO

FILO is a nonprofit, institutional group of clinical research in Chronic Lymphocytic Leukemia (LLC) Waldenstrom disease (MW)

FILO : Chronic Lymphoid Leukemia (CLL) and Waldenström's ...

A patient organization can help you to empathize with your patients ... Alfa Leukemia French Association; American Society oh Hematology; AML GLOBAL ...

French Innovative Leukemia Organization (FILO)

French Innovative Leukemia Organization (FILO) · Develop clinical and translational research · Promote prospective multi-centre clinical trials with an academic ...

French Innovative Leukemia Organization (FILO), France - Nature

Each position links to the corresponding table where French Innovative Leukemia Organization (FILO) is listed. Position by research output Share. Global, France ...

Publications - FILOThèque

... French Innovative Leukemia Organization. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk ...

FRENCH INNOVATIVE LEUKEMIA ORGANISATION (GROUPE FILO)

FRENCH INNOVATIVE LEUKEMIA ORGANISATION (GROUPE FILO). institutions.detail.person.activities. Public funding body; Sponsor of clinical trial.

Nos publications - FILO

... France: A study from the French Innovative Leukemia Organization (FILO) group. American Journal of Hematology 2017, 92 : E105-E107. Epub 2017 Apr 29. -Tout ...

French Innovative Leukemia Organization (FILO) | Institution outputs

The articles listed below published by authors from French Innovative Leukemia Organization (FILO), organized by journal and article, represent the research ...

Recommendations of the French CLL Study Group (FILO) - PubMed

The recommendations of the French Innovative Leukemia Organization (FILO-CLL) group presented here a …

(FILO) Study. of CLL patients after FCR. A French Innovative ...

of CLL patients after FCR. A French Innovative Leukemia Organization. Increased rituximab exposure does not improve response and outcome. Version 3. HAEMATOL ...

FRENCH INNOVATIVE LEUKEMIA ORGANIZATION (F.I.L.O.).

FRENCH INNOVATIVE LEUKEMIA ORGANIZATION (F.I.L.O.). Civic and Social Organizations. Tours, Centreval De Loire 31 followers.

Increased rituximab exposure does not improve response ... - PubMed

... leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study.

FILO French Innovative Leukemia Organization Trials - Larvol Sigma

Trial + Data / Events, Status, Ph, N, Region, Interventions, Sponsor, Conditions, Primary compl, Study compl. KILADJIAN, Jean Jacques ...

Paper: Lenalidomide Consolidation Improves Measurable Residual ...

... Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO). Program: Oral and Poster Abstracts Session: 642. Chronic ...

Recommendations for the Management of Patients with Hairy-Cell ...

... Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group. by. Jérôme Paillassa. Jérôme Paillassa.

Kinase Inhibitors (ibrutinib or idelalisib) in the Management of ...

... French Innovative Leukemia Organization (FILO). Author links open overlay panel. Sophie Godet MD * 1 2 , Anne Quinquenel * 1 2 , Caroline Dartigeas MD * 3

Clinical and biological characteristics of leukemia cutis in chronic ...

ACKNOWLEDGMENTS. The authors thank the French Innovative Leukemia Organization (FILO). CONFLICT OF INTEREST. The authors declare no conflict of ...

5.5-year results from the phase 2 ICLL-07 FILO trial | Blood Advances

the French Innovative Leukemia Organization (FILO) CLL group. Crossmark: Check for Updates. Blood Adv (2023) 7 (15): 3936–3945. https://doi ...

NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN ...

FILO members represent all French and Belgian specialists involved in the study of these diseases (apart from members of the Acute Leukemia French Association - ...

American Journal of Hematology - Wiley Online Library

... French Innovative Leukemia Organization (FILO) study. Lauren Véronèse,. Corresponding Author. Lauren Véronèse. [email protected] ...